MAPS Canada Podcast

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

The Multidisciplinary Association for Psychedelic Studies (MAPS) was formed in the US in 1986, in response to the US Drug Enforcement Agency’s classification of MDMA as Schedule 1 substance, and has been developing medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics since then. MAPS Canada was founded as a sister organization to MAPS in 2011, and is a...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

Working with partners in government, business, and the community, MAPS Canada is committed to advancing psychedelic medicine by supporting scientific, multidisciplinary research; advocating for drug policy reform; offering public education; and supporting equitable access to legal and regulated psychedelic medicine in Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS) was for...

"Isn't microdosing just placebo effect??" You may have heard this before but is it true? Dr. Zachary Walsh, a leading clinical psychologist and researcher, explores the therapeutic potential of psychedelics in this episode, focusing on psilocybin-assisted psychotherapy for opioid titration and his involvement in the Microdose.me study. He explains the distinction between cannabis, used for symptom...

Have you humbled yourself to your elders? These women elders of the psychedelic underground are spiritual warriors-fearless in their journeys to the shamanic realms. Rachel Harris, PhD, is the author of "Swimming in the Sacred: Wisdom from the Psychedelic Underground" and "Listening to Ayahuasca." A psychologist who has been in private practice for 40 years, she spent 10 years in an academic resea...

Michael Phillip is the creator and host of Third Eye Drops, a media vessel dedicated to philosophy, psychology, spirituality, meaning, and adventure (both physical and mental). Michael is a writer, podcast host, speaker, community-builder, and wonder junkie holding a B.A. in Journalism. Check it out at https://thirdeyedrops.com/ And consider donating to MAPS Canada at https://mapscanada.org/donate...

Don Lattin is a veteran religion journalist and award-winning author of several books on psychedelics including The Harvard Psychedelic Club and his latest book God on Psychedelics. He was a speaker at Psychedelic Science 2023, the world biggest ever conference on psychedelics, and he has been closely following the movement from it's beginnings. In this podcast, hear Don Lattin's perspective on th...

David Bronner is the CEO (Cosmic Engagement Officer) of Dr. Bronners as well as a board member of MAPS and a long-time activist and leader in the psychedelic, hemp and organic-fair trade movements.

Listen to this interview with Rick Doblin on new results from the MAPS Phase III clinical trials for MDMA assisted therapy, the upcoming biggest psychedelic conference in the world ever—Psychedelic Science 2023—and stories of getting banned from the U.S for life. Rick Doblin, Ph. D., is the founder and president of the Multidisciplinary Association for Psychedelic Studies (MAPS) founded in 1986. M...

In this episode Dennis McKenna joins MAPS Canada in discussing Ayahuasca tourism, the McKenna Academy of Natural Philosophy, Biognosis, the future of the psychedelic movement and the counter-force to the movement—the "war on consciousness". Dennis McKenna has conducted research in ethnopharmacology for over 40 years. He is a founding board member of the Heffter Research Institute and was a key inv...

🇺🇦 Meet the researcher conducting research to bring MDMA assisted therapy to Ukrainian refugees abroad and ultimately, to the countless victims of the Ukraine War. In this MAPS Canada Podcast episode, Luc Briedé-Cooper and Sabrina Ramkellawan sit down with Dr. Olga Chernoloz a Ukrainian researcher based in Canada. Become part of the psychedelic movement by donating at: https://mapscanada.org/donat...